Manufacturing and Import Business Licences under the Korean Medical Device Act

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The first step of the Korean medical device business is not filing a product but obtaining a business licence. The Medical Device Act sets two licences by business form: the licence for manufacturing business (Article 6) and the licence for import business (Article 15). Only the holders of these two licences can proceed to apply for item licences, item certification or item notification.

Facility requirements differ by business form. Manufacturing requires a manufacturing site, laboratory and storage facilities, plus a quality manager; importing requires a business premises, storage facilities and quality inspection facilities, likewise with a quality manager. Both must have a quality manager, which is the common element.

For Chinese manufacturers entering the Korean market, the route is the import business licence: a licensed entity in Korea (KLH) holds the import business licence and the import item licences, the manufacturing site remains offshore, and its quality system is confirmed through the KGMP conformity audit. GRZAN advises treating the question of whether the facilities and personnel of the licensed entity continuously meet the statutory conditions as an annual review item, not as a one-time check at application.

2. Legal basis

The two business licences and their statutory conditions rest on the following instruments.

RegulationNumberPublication dateProvisions
Medical Device ActAct No. 6909 (enactment); No. 17248 (2020 amendment)Enacted and promulgated 29 May 2003Article 6 (licence for manufacturing business), Article 15 (licence for import business), Article 49 (item renewal)
Enforcement Rule of the Medical Device ActPrime Ministerial Decree No. 2127Partially amended and promulgated 1 July 2026, effective the same dayAppendix Table 1 (standards and procedures for medical device classification and designation)
Standards for Medical Device Manufacturing and Quality Management (KGMP)MFDS Notification No. 2023-792023Mandatory for Classes 2 to 4, certificate valid 3 years
Regulations on Approval, Certification, Notification, etc. of Medical DevicesMFDS Notification No. 2022-52Effective 29 July 2022Licence application procedures and document requirements

Comparison of the statutory conditions of the two business licences (supplementary table)

ItemManufacturing licence (Article 6)Import business licence (Article 15)
PremisesManufacturing siteBusiness premises
FacilitiesLaboratory, storage facilitiesStorage facilities, quality inspection facilities and equipment
PersonnelQuality managerQuality manager
Quality systemKGMP conformity audit (Classes 2 to 4)KGMP conformity audit (Classes 2 to 4, offshore manufacturing site)
Follow-on obligationItem renewal (every 5 years)Item renewal (every 5 years)

3. Expert insights

Insight 1: The business licence and the item licence are two levels of licence and must not be merged into one concept.

The business licence answers whether the business may be conducted at all; the item licence, certification or notification answers whether this product may be sold. What GRZAN has encountered in projects is a company that treated the two as a single application and prepared documents along the item dimension, only to find the file not accepted because the conditions of the business licence were unmet. The sequence of the two levels is fixed: business licence first, item licence afterwards.

Insight 2: The quality inspection facilities of the import business licence are often underestimated.

The holder of an import business licence must have quality inspection facilities and equipment for inspecting imported products. A holder with only a warehouse and office space will be required to supplement them in the licence review. GRZAN advises verifying these three items on site when selecting a licensed entity, rather than reading only the business scope on the registration certificate.

Insight 3: Offshore manufacturing sites connect through the KGMP audit, with the certificate valid 3 years.

For Chinese manufacturers the manufacturing site is offshore, and its quality system is confirmed through the KGMP conformity audit (MFDS Notification No. 2023-79), with the certificate valid 3 years. The KGMP and the import business licence belong to two separate systems, yet the lapse of either one affects the actual conduct of the import business.

Insight 4: The business licence also sits inside the item renewal system.

Article 49 of the Medical Device Act, as amended by Act No. 17248 with effect from 8 October 2020, requires manufacturing licences, manufacturing certifications, manufacturing notifications, import licences, import certifications and import notifications to be renewed every 5 years. Obtaining the business licence is not once and for all; it must be managed on a compliance calendar.

4. Practical recommendations

  • Verify the business licence before touching the item documents. GRZAN advises confirming at the project kick-off meeting that the licensed entity’s import business licence is within its validity and that the facilities and the quality manager are in place.
  • Verify the three hardware items on site. Photograph and archive the business premises, the storage facilities and the quality inspection facilities and equipment item by item, as evidence for licence maintenance.
  • Merge the KGMP and business licence validity onto one calendar. The KGMP certificate is valid 3 years and items must be renewed every 5 years; the two cycles are not synchronised and managing them separately easily misses items.
  • Write the quality manager arrangement into the contract terms. Agree with the licensed entity on the presence-in-post of the quality manager and the duty to notify of changes, so that personnel turnover does not undermine the licence conditions.
  • Report changes promptly. Relocation of the business premises and adjustment of storage facilities are licence matters; changing them without reporting creates compliance risk.

5. Verification checklist

  • □ Type of business licence: confirm a manufacturing licence or an import business licence; matched to the actual business form.
  • □ Premises conditions: verify the business premises or manufacturing site on site; identical to the licence registration.
  • □ Facility conditions: check the storage facilities and the quality inspection facilities and equipment; the equipment list is complete and usable.
  • □ Quality manager in post: check the employment certificate and the registration information; full-time, in post and registered.
  • □ KGMP status: check the certificate validity period; valid for 3 years and not expired.
  • □ Item renewal cycle: check the date of the last renewal; renewal completed within the 5-year cycle.
  • □ Change reporting: check the records of premises and facility changes; reported after each change.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, Korean licence holder and local testing support for the Republic of Korea. Our team manages MFDS premarket approvals and KGMP conformity, coordinates import requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail